1. Association of VEGFA polymorphisms with chronic obstructive pulmonary disease in Chinese Han and Mongolian populations
    Xiaoyu Gao et al, 2021, Experimental Physiology CrossRef
  2. Non-invasive quantification of cell-free DNA mutations in plasma during lung tumor progression in mice
    Soo-Jin Kim et al, 2017, Cancer Biomarkers CrossRef
  3. Prospective Exploratory Analysis of Angiogenic Biomarkers in Peripheral Blood in Advanced NSCLC Patients Treated With Bevacizumab Plus Chemotherapy: The ANGIOMET Study
    Eloisa Jantus-Lewintre et al, 2021, Frontiers in Oncology CrossRef
  4. Study of single nucleotide polymorphism of vascular endothelium factor in patients with differentiated thyroid cancer
    Mohamad Mohsen Motawea et al, 2022, Clinical Diabetes and Endocrinology CrossRef
  5. Retinoblastoma Binding Protein 2 (RBP2) Promotes HIF-1α–VEGF-Induced Angiogenesis of Non-Small Cell Lung Cancer via the Akt Pathway
    Lei Qi et al, 2014, PLoS ONE CrossRef
  6. Hedgehog/Gli1 signal pathway facilitates proliferation, invasion, and migration of cutaneous SCC through regulating VEGF
    Qian Sun et al, 2016, Tumor Biology CrossRef
  7. Impact ofVEGFgene polymorphisms in elderly cancer patients: clinical outcome and toxicity
    David Della-Morte et al, 2015, Pharmacogenomics CrossRef
  8. Association of VEGF Gene Polymorphisms with the Risk and Prognosis of Cutaneous Squamous Cell Carcinoma
    Xiao-juan Nie et al, 2016, Medical Science Monitor CrossRef
  9. Non Melanoma Skin Cancer Pathogenesis Overview
    Dario Didona et al, 2018, Biomedicines CrossRef
  10. Polymorphisms in VEGF-A are associated with COPD risk in the Chinese population from Hainan province
    YIPENG DING et al, 2016, Journal of Genetics CrossRef
  11. Prognostic effect of VEGF gene variants in metastatic non-small-cell lung cancer patients
    Ivana Sullivan et al, 2019, Angiogenesis CrossRef
  12. Genetic polymorphisms of vascular endothelial growth factor (VEGF) associated with gastric cancer recurrence after curative resection with adjuvant chemotherapy
    Yeon-Ji Kim et al, 2019, BMC Cancer CrossRef

  13. The Role of DLLs in Cancer: A Novel Therapeutic Target


    Meng-Xi Xiu et al, 2020, OncoTargets and Therapy CrossRef
  14. Correlation of genetic polymorphism of vascular endothelial growth factor gene with susceptibility to lung cancer
    C Liu et al, 2015, Cancer Gene Therapy CrossRef
  15. A Vascular Endothelial Growth Factor Gene Polymorphism Predicts Malignant Potential in Intraductal Papillary Mucinous Neoplasm
    Norimitsu Yabusaki et al, 2015, Pancreas CrossRef
  16. The impact of cigarette smoke on activity of single nucleotide polymorphisms of the vascular endothelial growth factor‐promoter gene in cells of the upper aerodigestive tract
    Maximilian Krüger et al, 2019, Journal of Oral Pathology & Medicine CrossRef
  17. CXC chemokine ligand 4 (CXCL4) is predictor of tumour angiogenic activity and prognostic biomarker in non-small cell lung cancer (NSCLC) patients undergoing surgical treatment
    Artjoms Spaks et al, 2016, Biomarkers CrossRef
  18. KRAS genetic variant as a prognostic factor for recurrence in resectable non-small cell lung cancer
    I. Sullivan et al, 2017, Clinical and Translational Oncology CrossRef
  19. Cigarette smoke modulates binding of the transcription factor MZF1 to the VEGF promoter and regulates VEGF expression in dependence of genetic variation SNP 405
    Maximilian Krüger et al, 2020, Journal of Oral Pathology & Medicine CrossRef